ACCUPAQUE™ 350 Injektionslösung oder Lösung zum Einnehmen

DRUG2 trials

Sponsors

Universitaetsklinikum Erlangen AöR, Universitaet Leipzig

Conditions

Peripheral Arterial Disease (PAD)type 2 diabetes mellitus

Phase 3

Effects of Finerenone on Renal Hemodynamics and Oxidative Stress

CompletedCTIS2023-508266-15-00

Universitaetsklinikum Erlangen AöRtype 2 diabetes mellitus

Start: 2024-01-18End: 2025-11-25Target: 75Updated: 2024-08-16

A contrast medium sparing strategy using automated Carbon Dioxide Injection during PERIpheral vascular interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT randomized controlled trial

RecruitingCTIS2024-512876-37-00

Universitaet LeipzigPeripheral Arterial Disease (PAD)

Start: 2025-04-11Target: 1960Updated: 2025-11-06